TS Financial Group (TSFG)’s Day One Biopharmaceuticals DAWN Stock Holding History

TS Financial Group (TSFG)’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,400	Closed	-$73K	–	867
2026 Q1	$73K	Hold	3,400	–	–	0.01%	290
2025 Q4	$32K	Hold	3,400	–	–	﹤0.01%	410
2025 Q3	$24K	Hold	3,400	–	–	﹤0.01%	446
2025 Q2	$22K	Hold	3,400	–	–	﹤0.01%	444
2025 Q1	$27K	Hold	3,400	–	–	0.01%	406
2024 Q4	$43K	Hold	3,400	–	–	0.01%	312
2024 Q3	$47K	Buy	3,400 +400	+13%	+$5.71K	0.01%	298
2024 Q2	$41K	Hold	3,000	–	–	0.01%	300
2024 Q1	$50K	Buy	+3,000	New	+$44.9K	0.01%	270

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TS Financial Group (TSFG)'s DAWN Position: Q2 2026 in Review

TS Financial Group (TSFG) sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 3,400 shares — an estimated $73K sold.

TS Financial Group (TSFG) first reported a position in DAWN in Q1 2024 and held it in 9 quarters. The position peaked at $73K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

TS Financial Group (TSFG) reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
TS Financial Group (TSFG) sold 3,400 Day One Biopharmaceuticals shares in Q2 2026, an estimated $73K.
TS Financial Group (TSFG) first reported a position in Day One Biopharmaceuticals in Q1 2024 and held it in 9 quarters.
TS Financial Group (TSFG)'s Day One Biopharmaceuticals position peaked at $73K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.